Learn how a novel combination of Botensilimab and Balstilimab demonstrates promising efficacy in traditionally immunotherapy-resistant sarcomas.

Paediatric bone sarcomas (e.g. Ewing sarcoma, osteosarcoma) comprise significant biological and clinical heterogeneity. This extreme heterogeneity affects response to systemic therapy, facilitates inh...

Brave mum Gail Redpath is undergoing palliative chemotherapy after doctors found a golf ball-sized growth in her womb - which was a very rare form of cancer

In this Sarcoma Talk, Dr. Michael J. Wagner, Medical Oncologist at Dana-Farber Cancer Institute, joins host Shushan Hovsepyan. Dr. Wagner discusses the latest advancements in angiosarcoma treatment, highlighting the challenges of diagnosing this rare cancer. He explores the molecular differences between cutaneous, hepatic, and breast angiosarcomas, and shares insights into new therapeutic strategies and clinical trials. #Cancer #SarcomaTalk #OncoDaily #SarcomaResearch #Immunotherapy #CancerResearch #CancerTreatment # MichaelWagner #ClinicalTrials #ShushanHovsepyan #Angiosarcoma #CancerBreakthroughs #PrecisionOncology #CancerImmunotherapy 00:00 Introduction to Angiosarcoma 02:30 Locations and molecular differences: skin, liver, and breast 05:12 Scalp and face tumors linked to UV exposure; responsive to immunotherapy 07:45 Diagnostic challenges and the need for expert pathology 09:32 Treatment options 12:10 Ongoing research and future directions 13:25 Closing thoughts on advances and challenges in angiosarcoma treatment SUBSCRIBE to get the latest #oncodaily https://www.youtube.com/@OncoDailyTV Visit the OncoDaily Website : https://oncodaily.com Like OncoDaily on LinkedIn: https://linkedin.com/company/oncodaily Like OncoDaily on X (Twitter): https://x.com/oncodaily Follow OncoDaily on Instagram: https://www.instagram.com/oncodailynews/ Follow OncoDaily on TikTok: https://www.tiktok.com/@oncodaily Like OncoDaily on Facebook: https://www.facebook.com/oncodaily/ SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter About OncoDaily OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”